vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Community West Bancshares (CWBC). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $38.3M, roughly 1.2× Community West Bancshares). On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 11.6%). Community West Bancshares produced more free cash flow last quarter ($43.6M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 36.0%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Community West BancsharesCWBCEarnings & Financial Report
Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.
ABCL vs CWBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $38.3M |
| Net Profit | $-8.9M | — |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 40.0% |
| Net Margin | -19.9% | — |
| Revenue YoY | 788.4% | 11.6% |
| Net Profit YoY | 73.9% | — |
| EPS (diluted) | $-0.03 | $0.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $38.3M | ||
| Q3 25 | $9.0M | $37.9M | ||
| Q2 25 | $17.1M | $35.7M | ||
| Q1 25 | $4.2M | $34.8M | ||
| Q4 24 | $5.0M | $34.3M | ||
| Q3 24 | $6.5M | $31.3M | ||
| Q2 24 | $7.3M | $30.5M | ||
| Q1 24 | $10.0M | $20.7M |
| Q4 25 | $-8.9M | — | ||
| Q3 25 | $-57.1M | $10.9M | ||
| Q2 25 | $-34.7M | $7.8M | ||
| Q1 25 | $-45.6M | $8.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-51.1M | $3.4M | ||
| Q2 24 | $-36.9M | $-6.3M | ||
| Q1 24 | $-40.6M | $3.7M |
| Q4 25 | -63.7% | 40.0% | ||
| Q3 25 | -851.8% | 39.8% | ||
| Q2 25 | -290.2% | 30.2% | ||
| Q1 25 | -1479.6% | 32.7% | ||
| Q4 24 | — | 31.0% | ||
| Q3 24 | -1439.4% | 13.3% | ||
| Q2 24 | -1276.2% | -25.9% | ||
| Q1 24 | -551.5% | 23.2% |
| Q4 25 | -19.9% | — | ||
| Q3 25 | -637.8% | 28.7% | ||
| Q2 25 | -203.3% | 22.0% | ||
| Q1 25 | -1077.2% | 23.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | -785.4% | 10.8% | ||
| Q2 24 | -504.3% | -20.7% | ||
| Q1 24 | -408.0% | 17.8% |
| Q4 25 | $-0.03 | $0.58 | ||
| Q3 25 | $-0.19 | $0.57 | ||
| Q2 25 | $-0.12 | $0.41 | ||
| Q1 25 | $-0.15 | $0.44 | ||
| Q4 24 | — | $0.29 | ||
| Q3 24 | $-0.17 | $0.18 | ||
| Q2 24 | $-0.13 | $-0.33 | ||
| Q1 24 | $-0.14 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $119.0M |
| Total DebtLower is stronger | — | $69.5M |
| Stockholders' EquityBook value | $966.9M | $409.6M |
| Total Assets | $1.4B | $3.7B |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $119.0M | ||
| Q3 25 | $83.2M | $121.6M | ||
| Q2 25 | $92.4M | $134.4M | ||
| Q1 25 | $159.3M | $148.4M | ||
| Q4 24 | $156.3M | $120.4M | ||
| Q3 24 | $126.6M | $149.0M | ||
| Q2 24 | $148.3M | $109.7M | ||
| Q1 24 | $123.6M | $61.0M |
| Q4 25 | — | $69.5M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $69.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $966.9M | $409.6M | ||
| Q3 25 | $964.0M | $397.6M | ||
| Q2 25 | $1.0B | $380.0M | ||
| Q1 25 | $1.0B | $372.2M | ||
| Q4 24 | $1.1B | $362.7M | ||
| Q3 24 | $1.1B | $363.5M | ||
| Q2 24 | $1.1B | $350.2M | ||
| Q1 24 | $1.1B | $211.7M |
| Q4 25 | $1.4B | $3.7B | ||
| Q3 25 | $1.4B | $3.6B | ||
| Q2 25 | $1.4B | $3.6B | ||
| Q1 25 | $1.3B | $3.6B | ||
| Q4 24 | $1.4B | $3.5B | ||
| Q3 24 | $1.4B | $3.5B | ||
| Q2 24 | $1.4B | $3.5B | ||
| Q1 24 | $1.5B | $2.4B |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $46.1M |
| Free Cash FlowOCF − Capex | $-44.6M | $43.6M |
| FCF MarginFCF / Revenue | -99.4% | 113.9% |
| Capex IntensityCapex / Revenue | 21.9% | 6.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $77.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $46.1M | ||
| Q3 25 | $-52.6M | $13.2M | ||
| Q2 25 | $-32.4M | $11.5M | ||
| Q1 25 | $-11.6M | $11.1M | ||
| Q4 24 | $-108.6M | $22.2M | ||
| Q3 24 | $-28.9M | $7.8M | ||
| Q2 24 | $-30.0M | $5.2M | ||
| Q1 24 | $-41.7M | $4.0M |
| Q4 25 | $-44.6M | $43.6M | ||
| Q3 25 | $-61.5M | $12.8M | ||
| Q2 25 | $-45.8M | $10.6M | ||
| Q1 25 | $-22.2M | $10.8M | ||
| Q4 24 | $-187.0M | $17.2M | ||
| Q3 24 | $-47.4M | $5.2M | ||
| Q2 24 | $-50.1M | $4.8M | ||
| Q1 24 | $-65.8M | $3.6M |
| Q4 25 | -99.4% | 113.9% | ||
| Q3 25 | -687.0% | 33.7% | ||
| Q2 25 | -267.9% | 29.6% | ||
| Q1 25 | -524.0% | 30.9% | ||
| Q4 24 | -3702.8% | 50.0% | ||
| Q3 24 | -728.4% | 16.7% | ||
| Q2 24 | -683.8% | 15.7% | ||
| Q1 24 | -661.5% | 17.3% |
| Q4 25 | 21.9% | 6.6% | ||
| Q3 25 | 99.7% | 1.1% | ||
| Q2 25 | 78.2% | 2.7% | ||
| Q1 25 | 251.1% | 0.9% | ||
| Q4 24 | 1552.7% | 14.7% | ||
| Q3 24 | 284.6% | 8.1% | ||
| Q2 24 | 274.6% | 1.4% | ||
| Q1 24 | 242.5% | 2.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.21× | ||
| Q2 25 | — | 1.47× | ||
| Q1 25 | — | 1.33× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.29× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
